Atlas Trials

A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma

Clinical trial NCT07342322 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07342322
Sponsor
First Affiliated Hospital of Guangxi Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Soft Tissue Sarcoma (STS)
Start date
2026-02-01
Primary completion
2026-02-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.